Correction: Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia. [PDF]
Sharman JP +26 more
europepmc +1 more source
Ruxolitinib Versus Best Available Therapy in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease: Final Analysis From the Randomized Phase III REACH2 Trial. [PDF]
Mohty M +19 more
europepmc +1 more source
Bases physiopathologiques en hématologie générale : un aide-mémoire d'hématologie
P.M. Schmidt +5 more
openalex +1 more source
A longitudinal study of right ventricular function of patients with multiple myeloma treated with carfilzomib. [PDF]
Basin S +10 more
europepmc +1 more source
Predicting the toxicity-efficacy ratio of venetoclax in real-world patients. [PDF]
Osanno L +16 more
europepmc +1 more source
L'examen cytogénétique en onco-hématologie : son importance dans la stratégie thérapeutique
J. Collignon +3 more
openalex +1 more source
Mise en place de consultations pharmaceutiques en hématologie : rôle du pharmacien
Matthieu Manoukian
openalex +1 more source
Carnet de pédiatrie: hématologie et douleur de l'enfant
Oreste Battisti +1 more
openalex +1 more source

